Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth: [NA]

View source ↗

Summary

A University of Roma La Sapienza-led clinical trial is evaluating a multi-nutrient combination of magnesium, palmitoylethanolamide, high-molecular-weight hyalur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-molecular-weight hyaluronic acid (Hyaluronic acid)
  • Magnesium (magnesium)
  • Palmitoylethanolamide (palmitoylethanolamide)
  • Vitamin B6 (pyridoxine)
  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Preterm Labor | NA | Status: NOT_YET_RECRUITING